Medline (NASDAQ:MDLN) Director Andrew Mills Purchases 2,586,206 Shares

Medline (NASDAQ:MDLN) Director Andrew Mills acquired 2,586,206 shares of Medline stock in a transaction that occurred on Thursday, December 18th. The stock was purchased at an average cost of $29.00 per share, with a total value of $74,999,974.00. Following the completion of the purchase, the director owned 2,586,206 shares in the company, valued at $74,999,974. The trade was a ? increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Medline Stock Up 1.3%

MDLN traded up $0.53 on Monday, hitting $42.18. 7,276,165 shares of the company’s stock were exchanged, compared to its average volume of 13,896,218. Medline has a fifty-two week low of $34.89 and a fifty-two week high of $43.90.

About Medline

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply?chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.